Omega Healthcare Investors (OHI)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-09
$47.19+0.34%
Close 2026-09-09 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-09
Intact: The reason to own it still holds.
Omega Healthcare Investors keeps paying a steady dividend of $0.67 per share. Revenue rose to about $323 million in the latest quarter. Net income improved strongly to $151 million from a prior loss. The company benefits from stable demand in healthcare real estate.
Revenue is expected to decline about 4% next year. The stock trades at a high price relative to earnings and cash flow. Rising costs or weaker demand could hurt profits and dividends.
The stock price is about 44% above our valuation level and 31% below the Street median. Analysts expect revenue to fall about 4% next year. Our view sees risks to growth and income that the current price does not fully reflect.
Breaks if: dividend per share falls below $0.67 next 4 quarters
Breaks if: EPS guidance falls below $3.19 for FY 2026
Breaks if: net income falls below zero next 4 quarters
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
OHI represents a durable compounder with a focus on real estate and loan investments. The current thesis state is intact, supported by robust earnings quality and a commitment to dividend growth.
The market appears to be pricing in a low level of fragility, with expectations for future performance not fully justified by current valuations. OHI is considered cheap compared to its peers, with a notable expectations gap.
Fundamentals are likely to remain strong, given management's consistent execution on capital allocation and dividend increases. However, there is a moderate risk due to the high miss rate in the industry, despite a low probability of missing expectations in the near term.
The thesis hinges on key factors such as the potential for the Federal Reserve to cut interest rates and the performance of sector bellwethers like WELL, VTR, and DOC. Any reversal in guidance from OHI could negatively impact credibility and performance.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: quarterly revenue falls below $319 million
Overall, OHI's position is supported by strong management execution and recent financial performance, but it faces sector headwinds and potential risks. Not investment advice.